Sirolimus Alternatives Compared
| Sirolimus | Tacrolimus | CellCept (mycophenolate mofetil) |
|
|---|
| Sirolimus | Tacrolimus | CellCept (mycophenolate mofetil) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Lymphangioleiomyomatosis, Organ Transplant - Rejection Prophylaxis. Sirolimus may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Organ Transplant - Rejection Reversal, Organ Transplant - Rejection Prophylaxis, Nephrotic Syndrome, Graft Versus Host Disease, Crohn's Disease. Tacrolimus may also be used for... View more |
Prescription only
Prescribed for Organ Transplant - Rejection Prophylaxis. CellCept may also be used for purposes not listed in this medication guide. |
Related suggestions Organ Transplant, Rejection Prophylaxis
Popular comparisons
|
|||||||||||||||||||||||
| More about Sirolimus | More about Tacrolimus | More about CellCept (mycophenolate mofetil) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Sirolimus has an average rating of 6.0 out of 10 from a total of 8 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 38% reported a negative effect. |
Tacrolimus has an average rating of 7.9 out of 10 from a total of 49 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 12% reported a negative effect. |
CellCept has an average rating of 8.3 out of 10 from a total of 35 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Sirolimus side effects |
View all Tacrolimus side effects |
View all CellCept side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Sirolimus prices |
View all Tacrolimus prices |
View all CellCept prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Rapamune | Astagraf XL, Envarsus XR, Prograf | Other mycophenolate mofetil brands include: Myhibbin | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
78 hours |
21.2 hours |
18 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 718 drugs are known to interact with Sirolimus:
|
A total of 870 drugs are known to interact with Tacrolimus:
|
A total of 347 drugs are known to interact with CellCept:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
September 15, 1999 |
April 08, 1994 |
May 03, 1995 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
CellCept
Cellcept (mycophenolate mofetil) is used to prevent rejection of a kidney, liver, or heart ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Prograf
Prograf is used to prevent your body from rejecting a heart, liver, or kidney transplant. Learn ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Envarsus XR
Envarsus XR is used for organ transplant, rejection prophylaxis
Rapamune
Rapamune (sirolimus) is used to prevent rejection in people who have received a kidney transplant ...
Sandimmune
Sandimmune is used for organ transplant, rejection prophylaxis
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.